ticlopidine has been researched along with Nephrotic Syndrome in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Nephrotic Syndrome: A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duan, S | 1 |
Luo, J | 1 |
Liu, F | 1 |
Kato, Y | 1 |
Kobayashi, H | 1 |
Mihara, H | 1 |
Mizutani, Y | 1 |
Kamijima, S | 1 |
Tanaka, A | 1 |
Takeda, H | 1 |
Kato, R | 1 |
Oguri, T | 1 |
1 trial available for ticlopidine and Nephrotic Syndrome
Article | Year |
---|---|
[Assessment of anticoagulant therapy in primary nephrotic syndrome].
Topics: Adolescent; Adult; Anticoagulants; Endothelins; Female; Fibrinolytic Agents; Heparin, Low-Molecular- | 1999 |
1 other study available for ticlopidine and Nephrotic Syndrome
Article | Year |
---|---|
Ticlopidine treatment in idiopathic plasmacytic lymphadenopathy with polyclonal hyperimmunoglobulinemia accompanied by nephrotic syndrome.
Topics: Adult; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Hypergammaglo | 1992 |